vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and IMAX CORP (IMAX). Click either name above to swap in a different company.

COHEN & STEERS, INC. is the larger business by last-quarter revenue ($143.8M vs $125.2M, roughly 1.1× IMAX CORP). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs 0.5%, a 23.7% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs 2.9%). IMAX CORP produced more free cash flow last quarter ($28.0M vs $-126.4M). Over the past eight quarters, IMAX CORP's revenue compounded faster (25.8% CAGR vs 8.3%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.

CNS vs IMAX — Head-to-Head

Bigger by revenue
CNS
CNS
1.1× larger
CNS
$143.8M
$125.2M
IMAX
Growing faster (revenue YoY)
IMAX
IMAX
+32.2% gap
IMAX
35.1%
2.9%
CNS
Higher net margin
CNS
CNS
23.7% more per $
CNS
24.3%
0.5%
IMAX
More free cash flow
IMAX
IMAX
$154.4M more FCF
IMAX
$28.0M
$-126.4M
CNS
Faster 2-yr revenue CAGR
IMAX
IMAX
Annualised
IMAX
25.8%
8.3%
CNS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNS
CNS
IMAX
IMAX
Revenue
$143.8M
$125.2M
Net Profit
$34.9M
$637.0K
Gross Margin
57.6%
Operating Margin
28.0%
19.3%
Net Margin
24.3%
0.5%
Revenue YoY
2.9%
35.1%
Net Profit YoY
-23.9%
-88.0%
EPS (diluted)
$0.67
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
IMAX
IMAX
Q4 25
$143.8M
$125.2M
Q3 25
$141.7M
$106.7M
Q2 25
$136.1M
$91.7M
Q1 25
$134.5M
$86.7M
Q4 24
$139.8M
$92.7M
Q3 24
$133.2M
$91.5M
Q2 24
$121.7M
$89.0M
Q1 24
$122.7M
$79.1M
Net Profit
CNS
CNS
IMAX
IMAX
Q4 25
$34.9M
$637.0K
Q3 25
$41.7M
$20.7M
Q2 25
$36.8M
$11.3M
Q1 25
$39.8M
$2.3M
Q4 24
$45.8M
$5.3M
Q3 24
$39.7M
$13.9M
Q2 24
$31.8M
$3.6M
Q1 24
$34.0M
$3.3M
Gross Margin
CNS
CNS
IMAX
IMAX
Q4 25
57.6%
Q3 25
63.1%
Q2 25
58.5%
Q1 25
61.4%
Q4 24
52.2%
Q3 24
55.8%
Q2 24
49.4%
Q1 24
59.3%
Operating Margin
CNS
CNS
IMAX
IMAX
Q4 25
28.0%
19.3%
Q3 25
34.5%
27.2%
Q2 25
31.8%
15.6%
Q1 25
33.6%
19.3%
Q4 24
35.3%
10.3%
Q3 24
33.7%
21.2%
Q2 24
31.5%
3.2%
Q1 24
32.8%
15.3%
Net Margin
CNS
CNS
IMAX
IMAX
Q4 25
24.3%
0.5%
Q3 25
29.4%
19.4%
Q2 25
27.1%
12.3%
Q1 25
29.6%
2.7%
Q4 24
32.8%
5.7%
Q3 24
29.8%
15.2%
Q2 24
26.1%
4.0%
Q1 24
27.7%
4.1%
EPS (diluted)
CNS
CNS
IMAX
IMAX
Q4 25
$0.67
$0.02
Q3 25
$0.81
$0.37
Q2 25
$0.72
$0.20
Q1 25
$0.77
$0.04
Q4 24
$0.89
$0.09
Q3 24
$0.77
$0.26
Q2 24
$0.63
$0.07
Q1 24
$0.68
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
IMAX
IMAX
Cash + ST InvestmentsLiquidity on hand
$145.5M
$151.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$562.0M
$337.9M
Total Assets
$876.7M
$894.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
IMAX
IMAX
Q4 25
$145.5M
$151.2M
Q3 25
$98.1M
$143.1M
Q2 25
$95.4M
$109.3M
Q1 25
$65.2M
$97.1M
Q4 24
$183.0M
$100.6M
Q3 24
$106.5M
$104.5M
Q2 24
$122.0M
$91.6M
Q1 24
$99.5M
$81.0M
Stockholders' Equity
CNS
CNS
IMAX
IMAX
Q4 25
$562.0M
$337.9M
Q3 25
$550.3M
$349.5M
Q2 25
$528.5M
$320.4M
Q1 25
$507.7M
$299.5M
Q4 24
$511.7M
$299.5M
Q3 24
$491.0M
$289.4M
Q2 24
$463.2M
$267.2M
Q1 24
$378.9M
$258.8M
Total Assets
CNS
CNS
IMAX
IMAX
Q4 25
$876.7M
$894.0M
Q3 25
$801.6M
$889.6M
Q2 25
$751.0M
$868.6M
Q1 25
$834.9M
$848.3M
Q4 24
$812.4M
$830.4M
Q3 24
$727.8M
$847.6M
Q2 24
$784.1M
$827.4M
Q1 24
$680.7M
$824.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
IMAX
IMAX
Operating Cash FlowLast quarter
$-120.4M
$29.4M
Free Cash FlowOCF − Capex
$-126.4M
$28.0M
FCF MarginFCF / Revenue
-87.9%
22.3%
Capex IntensityCapex / Revenue
4.2%
1.1%
Cash ConversionOCF / Net Profit
-3.45×
46.11×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M
$118.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
IMAX
IMAX
Q4 25
$-120.4M
$29.4M
Q3 25
$55.1M
$67.5M
Q2 25
$-67.6M
$23.2M
Q1 25
$-108.9M
$7.0M
Q4 24
$96.7M
$11.5M
Q3 24
$25.6M
$35.3M
Q2 24
$31.4M
$35.0M
Q1 24
$4.9M
$-11.0M
Free Cash Flow
CNS
CNS
IMAX
IMAX
Q4 25
$-126.4M
$28.0M
Q3 25
$52.6M
$64.8M
Q2 25
$-69.8M
$20.9M
Q1 25
$-110.0M
$5.3M
Q4 24
$85.0M
$6.9M
Q3 24
$24.2M
$34.2M
Q2 24
$27.1M
$33.5M
Q1 24
$537.0K
$-12.1M
FCF Margin
CNS
CNS
IMAX
IMAX
Q4 25
-87.9%
22.3%
Q3 25
37.1%
60.7%
Q2 25
-51.3%
22.8%
Q1 25
-81.8%
6.1%
Q4 24
60.8%
7.4%
Q3 24
18.2%
37.3%
Q2 24
22.3%
37.6%
Q1 24
0.4%
-15.3%
Capex Intensity
CNS
CNS
IMAX
IMAX
Q4 25
4.2%
1.1%
Q3 25
1.8%
2.6%
Q2 25
1.6%
2.6%
Q1 25
0.8%
1.9%
Q4 24
8.3%
5.0%
Q3 24
1.1%
1.2%
Q2 24
3.5%
1.8%
Q1 24
3.5%
1.4%
Cash Conversion
CNS
CNS
IMAX
IMAX
Q4 25
-3.45×
46.11×
Q3 25
1.32×
3.27×
Q2 25
-1.84×
2.06×
Q1 25
-2.74×
2.99×
Q4 24
2.11×
2.16×
Q3 24
0.65×
2.54×
Q2 24
0.99×
9.78×
Q1 24
0.14×
-3.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNS
CNS

Segment breakdown not available.

IMAX
IMAX

Technology Sales$46.6M37%
Image Enhancement And Maintenance Services$38.1M30%
Joint Revenue Sharing Arrangement$20.4M16%
Maintenance$16.3M13%
Finance Income$2.8M2%
Other Content Solutions$1.6M1%

Related Comparisons